Pub. Date : 1993
PMID : 20301289
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | PMM2-CDG (CDG-Ia) CLINICAL CHARACTERISTICS: PMM2-CDG (CDG-Ia) (previously known as congenital disorder of glycosylation type 1a), the most common of a group of disorders of abnormal glycosylation of N-linked oligosaccharides, is divided into three types: infantile multisystem, late-infantile and childhood ataxia-intellectual disability, and adult stable disability. | n-linked oligosaccharides | phosphomannomutase 2 | Homo sapiens |
| 2 | PMM2-CDG (CDG-Ia) CLINICAL CHARACTERISTICS: PMM2-CDG (CDG-Ia) (previously known as congenital disorder of glycosylation type 1a), the most common of a group of disorders of abnormal glycosylation of N-linked oligosaccharides, is divided into three types: infantile multisystem, late-infantile and childhood ataxia-intellectual disability, and adult stable disability. | n-linked oligosaccharides | phosphomannomutase 2 | Homo sapiens |